However, the high expression of KRT6A did not appear to contribute to tumorigenesis and metastases, as the high-expression group of CRC had a better prognosis than the low-expression group of CRC in the TCGA cohort. The gene discussed is KRT6A; the disease is colorectal carcinoma.